Literature DB >> 9892874

Review article: coeliac disease and its management.

N D Parnell1, P J Ciclitira.   

Abstract

Coeliac disease (CD) is a disorder of the small intestine, characterized by villous atrophy, due to an intolerance to dietary gluten in genetically susceptible individuals, which responds to gluten withdrawal. The underlying immunological mechanisms causing the disorder are still being worked out. In recent years a wide range of clinical presentations has become increasingly apparent, as has a lengthening list of associated conditions. Severe malabsorption with steatorrhoea and profound weight loss is seen infrequently, perhaps as a result of earlier diagnosis and the recognition of 'silent' and 'latent' disease. The prevalence of CD as judged by population screening with, in particular, anti-endomysial antibodies, appears to be much higher than that found with clinically apparent cases. There are a variety of well recognized complications, the commonest probably being osteopenia and osteoporosis. The marked increased risk of lymphoma can be avoided by a strict gluten-free diet. Follow-up of patients needs to be lifelong with prompt investigation of new symptoms and blood test abnormalities.

Entities:  

Mesh:

Year:  1999        PMID: 9892874     DOI: 10.1046/j.1365-2036.1999.00448.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

1.  A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency.

Authors:  M R Howard; A J Turnbull; P Morley; P Hollier; R Webb; A Clarke
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

Review 2.  Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature.

Authors:  Abdullah M S Al-Osaimi; Carl L Berg
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

3.  Tobacco is a "weapon of mass destruction". Should western countries be invaded for that?

Authors:  P Chaturvedi
Journal:  Postgrad Med J       Date:  2004-08       Impact factor: 2.401

4.  Celiac disease in the Turkish population.

Authors:  Rengin Elsurer; Gonca Tatar; Halis Simsek; Yasemin H Balaban; Musa Aydinli; Cenk Sokmensuer
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

5.  The changing face of celiac disease.

Authors:  R Lad; K Jacobson
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

6.  Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease.

Authors:  Jan G M C Damoiseaux; Bas Bouten; Annick M L W Linders; Jos Austen; Caroline Roozendaal; Maurice G V M Russel; Pierre-Philippe Forget; Jan Willem Cohen Tervaert
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

7.  Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998.

Authors:  Marie-Hélène Metzger; Margit Heier; Markku Mäki; Enzo Bravi; Andrea Schneider; Hannelore Löwel; Thomas Illig; Detlef Schuppan; Heinz-Erich Wichmann
Journal:  Eur J Epidemiol       Date:  2006-04-29       Impact factor: 8.082

8.  Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population.

Authors:  Gonca Tatar; Rengin Elsurer; Halis Simsek; Yasemin H Balaban; Gulsen Hascelik; Osman I Ozcebe; Yahya Buyukasik; Cenk Sokmensuer
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 9.  Celiac disease: understanding the gluten-free diet.

Authors:  Karla A Bascuñán; María Catalina Vespa; Magdalena Araya
Journal:  Eur J Nutr       Date:  2016-06-22       Impact factor: 5.614

10.  Value of routine duodenal biopsy in diagnosing coeliac disease in patients with iron deficiency anaemia.

Authors:  A K Mandal; I Mehdi; S K Munshi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-08       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.